Billionaire Profile
D
Global Rank
#1630

Image: Clark, Henry Williams, 1825- | Public domain | via Wikimedia Commons

David Dean Halbert

CEO, Biotech
UNITED STATES
Real-Time Net Worth
$2.528B
Estimated based on Biotech stock value as of March 6, 2026
-0.27% (24h)
Age
70
Source
Biotech
Industry
Healthcare
Citizenship
UNITED STATES

Biography

David Dean Halbert is a prominent American entrepreneur and healthcare innovator, best known as the founder and CEO of Caris Life Sciences. With an estimated net worth of $3.0 billion in 2024, Halbert's wealth stems from his pioneering work in the biotech industry. His career has been marked by significant achievements, including founding AdvancePCS, a pharmacy benefits management company that he later sold for $7.5 billion. Halbert's unwavering dedication to personalized medicine and precision diagnostics has led Caris Life Sciences to become a leader in molecular science, with a mission to revolutionize cancer care.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

David Dean Halbert was born in Abilene, Texas, in 1956. Growing up in a family with a strong healthcare background, his father was a physician. Halbert's upbringing instilled in him a sense of stewardship and a commitment to using his resources effectively. He attended Abilene Christian University, graduating with a Bachelor of Business Administration in 1978. His Christian faith has been a guiding force in both his personal and professional life, shaping his approach to business and philanthropy.

Rise to Success

Halbert's entrepreneurial journey began in 1987 when he founded AdvancePCS, a pharmacy benefit management company. He served as Chairman and CEO, leading the company to become a publicly traded, Fortune 250 corporation with over $15 billion in annual revenue. AdvancePCS was later sold to Caremark in 2004 for $7.5 billion. Following the sale, Halbert formed Caris Capital in 2005, an investment firm where he managed and sold over $1.2 billion in assets.

In 2008, Halbert acquired Molecular Profiling Institute (MPI), an early-stage life sciences company. Renamed Caris Life Sciences, the company has become a leader in molecular science and artificial intelligence, focusing on precision medicine to improve cancer care. Caris Life Sciences went public in June 2025.

Key Business Strategies

Halbert's business strategies are centered around innovation and a patient-first approach. He emphasized the power of molecular research and AI in cancer diagnostics and treatment. Caris Life Sciences made the decision in 2018 to run every gene on every cancer patient, creating a large-scale clinico-genomic database to analyze and understand the complexity of diseases. This data-driven approach allows the company to identify unique ways to deal with each type of cancer.

Philanthropy

Halbert and his wife, Kathy, are committed philanthropists. They established the Caris Foundation in 2002, which supports communities in Africa and Haiti by addressing their basic needs. Through the Caris Foundation, they have provided medical care, support for hospitals, mentorship, and education programs. In 2014, they made a $15 million donation through the Caris Foundation to Abilene Christian University, contributing to the Halbert-Walling Research Center and Wildcat Stadium.

Career Milestones

1987

Founded AdvancePCS

Founded AdvancePCS, a pharmacy benefits management company.

2004

Sold AdvancePCS

Sold AdvancePCS to Caremark for $7.5 billion.

2005

Formed Caris Capital

Formed Caris Capital, an investment firm.

2008

Acquired Molecular Profiling Institute

Acquired Molecular Profiling Institute, which was later renamed Caris Life Sciences.

2023

Honorary Doctorate

Awarded an honorary Doctorate of Science by Abilene Christian University.

2025

Caris Life Sciences IPO

Caris Life Sciences went public on the NASDAQ.

Philanthropy & Social Impact

Healthcare and Humanitarian Aid

Caris Foundation

Undisclosed

Supports communities in Africa and Haiti by providing medical care, education, and disaster relief.

Education and Research

Halbert-Walling Research Center

$15M

Provided funding for the Halbert-Walling Research Center at Abilene Christian University, a research facility for science labs, classrooms, and offices.

Education and Sports

Wildcat Stadium

$3M

Contributed to the construction of the Chuck Sitton Tower at Wildcat Stadium at Abilene Christian University.

Business Philosophy & Leadership

Notable Quotes

"I fundamentally believed that if there was something wrong with the human body, there was something misfiring at the molecular level and technology advances could find that and diagnose it and possibly treat it."

"We’re now extending lives and improving lives and we’ve been doing it primarily in cancer."

Leadership Principles

Patient-First Approach

Prioritizing the needs and well-being of patients in all business decisions.

Innovation and Technology

Leveraging cutting-edge technology, including AI and molecular research, to improve healthcare outcomes.

Data-Driven Decision Making

Utilizing extensive data and analysis to inform strategies and drive advancements in precision medicine.